LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 962 | 8711 | 10605 | 0.8214 | 0.8036 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 962 | 8735 | 10605 | 0.8237 | 0.8061 |
MCF 10A | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 962 | 8775 | 10605 | 0.8274 | 0.8102 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8778 | 10605 | 0.8278 | 0.8106 |
MCF 10A | XL147 | 1.11 | uM | LJP5 | 72 | hr | 962 | 8797 | 10605 | 0.8295 | 0.8125 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 962 | 8802 | 10605 | 0.8300 | 0.8131 |
MCF 10A | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8808 | 10605 | 0.8306 | 0.8137 |
MCF 10A | CHIR-99021 | 10.0 | uM | LJP6 | 72 | hr | 962 | 8827 | 10605 | 0.8323 | 0.8156 |
MCF 10A | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 962 | 8878 | 10605 | 0.8372 | 0.8209 |
MCF 10A | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 962 | 8893 | 10605 | 0.8386 | 0.8225 |
MCF 10A | BMS345541 | 10.0 | uM | LJP6 | 72 | hr | 962 | 8900 | 10605 | 0.8392 | 0.8232 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8912 | 10605 | 0.8404 | 0.8245 |
MCF 10A | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 962 | 8937 | 10605 | 0.8427 | 0.8270 |
MCF 10A | PLX-4720 | 10.0 | uM | LJP5 | 72 | hr | 962 | 8942 | 10605 | 0.8432 | 0.8276 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 8953 | 10605 | 0.8442 | 0.8287 |
MCF 10A | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 962 | 8969 | 10605 | 0.8458 | 0.8304 |
MCF 10A | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 962 | 9031 | 10605 | 0.8516 | 0.8368 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9064 | 10605 | 0.8547 | 0.8402 |
MCF 10A | R406 | 1.11 | uM | LJP6 | 72 | hr | 962 | 9076 | 10605 | 0.8558 | 0.8414 |
MCF 10A | Crizotinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 9096 | 10605 | 0.8578 | 0.8436 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 962 | 9104 | 10605 | 0.8585 | 0.8444 |
MCF 10A | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9108 | 10605 | 0.8589 | 0.8448 |
MCF 10A | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9117 | 10605 | 0.8597 | 0.8457 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 962 | 9121 | 10605 | 0.8601 | 0.8461 |
MCF 10A | Alpelisib | 1.11 | uM | LJP5 | 72 | hr | 962 | 9137 | 10605 | 0.8616 | 0.8478 |